These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17888960)

  • 1. Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery.
    Dietrich W; Ebell A; Busley R; Boulesteix AL
    Ann Thorac Surg; 2007 Oct; 84(4):1144-50. PubMed ID: 17888960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of aprotinin use and re-use in pediatric cardiothoracic surgery.
    Jaquiss RD; Ghanayem NS; Zacharisen MC; Mussatto KA; Tweddell JS; Litwin SB
    Circulation; 2002 Sep; 106(12 Suppl 1):I90-4. PubMed ID: 12354715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions.
    Beierlein W; Scheule AM; Dietrich W; Ziemer G
    Ann Thorac Surg; 2005 Feb; 79(2):741-8. PubMed ID: 15680884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylactic reactions to aprotinin reexposure in cardiac surgery: relation to antiaprotinin immunoglobulin G and E antibodies.
    Dietrich W; Späth P; Zühlsdorf M; Dalichau H; Kirchhoff PG; Kuppe H; Preiss DU; Mayer G
    Anesthesiology; 2001 Jul; 95(1):64-71; discussion 5A-6A. PubMed ID: 11465586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An anaphylactic reaction after primary exposure to an aprotinin test dose in a child with a severe milk allergy.
    Kaddoum RN; Chidiac EJ; Zestos MM; Rajan SD; Baraka A
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):243-4. PubMed ID: 17418739
    [No Abstract]   [Full Text] [Related]  

  • 6. Invited commentary.
    Smith CR
    Ann Thorac Surg; 2007 Oct; 84(4):1150. PubMed ID: 17888961
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations.
    Dietrich W; Späth P; Ebell A; Richter JA
    J Thorac Cardiovasc Surg; 1997 Jan; 113(1):194-201. PubMed ID: 9011690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity reactions to aprotinin re-exposure in paediatric surgery.
    Siehr S; Stuth E; Tweddell J; Hoffman G; Troshynski T; Jones D; Mitchell M; Ghanayem N
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):307-11. PubMed ID: 19767215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of preformed aprotinin-specific antibodies in cardiosurgical patients.
    Scheule AM; Beierlein W; Arnold S; Eckstein FS; Albes JM; Ziemer G
    Anesth Analg; 2000 Feb; 90(2):262-6. PubMed ID: 10648304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of hypersensitivity reactions.
    Dietrich W
    Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S60-4; discussion S74-6. PubMed ID: 9647141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
    Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL.
    Wagener G; Gubitosa G; Wang S; Borregaard N; Kim M; Lee HT
    Am J Nephrol; 2008; 28(4):576-82. PubMed ID: 18264006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospective epidemiologic study of perioperative anaphylactoid reactions occurring in Catalonia (1996-7)].
    Escolano F; Valero A; Huguet J; Baxarias P; de Molina M; Castro A; Granel C; Sanosa J; Bartolomé B;
    Rev Esp Anestesiol Reanim; 2002; 49(6):286-93. PubMed ID: 12353405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
    Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
    Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal failure after cardiac surgery: timing of cardiac catheterization and other perioperative risk factors.
    Del Duca D; Iqbal S; Rahme E; Goldberg P; de Varennes B
    Ann Thorac Surg; 2007 Oct; 84(4):1264-71. PubMed ID: 17888981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients.
    Martin K; Wiesner G; Breuer T; Lange R; Tassani P
    Anesth Analg; 2008 Dec; 107(6):1783-90. PubMed ID: 19020118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China.
    Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Li L; Hu S
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody formation after drug administration during cardiac surgery: parameters for aprotinin use.
    Levy JH
    J Heart Lung Transplant; 1993; 12(1 Pt 1):S26-33. PubMed ID: 7680234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin.
    Dietrich W; Busley R; Boulesteix AL
    Anesthesiology; 2008 Feb; 108(2):189-98. PubMed ID: 18212563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of aprotinin use during cardiac surgery.
    Kristeller JL; Roslund BP; Stahl RF
    Pharmacotherapy; 2008 Jan; 28(1):112-24. PubMed ID: 18154481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.